Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Saved in:
| Title: | Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells. |
|---|---|
| Authors: | Yankelevich M; St. Christopher's Hospital for Children, Drexel University., Thakur A; University of Virginia., Modak S; Memorial Sloan Kettering Cancer Center., Chu R; Children's Hospital of Michigan (CHM), Wayne State University., Taub J; Children's Hospital of Michigan (CHM), Wayne State University., Martin A; Children's Hospital of Michigan (CHM), Wayne State University., Schalk DL; University of Virginia., Schienshang A; University of Virginia., Whitaker S; University of Virginia., Rea K; University of Virginia., Lee DW; University of Virginia., Liu Q; Wistar Institute., Shields A; Karmanos Cancer Institute and Wayne State University., Cheung NK; Memorial Sloan Kettering Cancer Center., Lum LG; University of Virginia. |
| Source: | Research square [Res Sq] 2023 Nov 09. Date of Electronic Publication: 2023 Nov 09. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
